Showing results (1911-1920 of 2,089) with videos related to

Sort By:
Pageof 209
Fa Yi Xue Za Zhi|June 5, 2023
Exploration and Practice of the "One Combination, Two Highlights, Three Combinations, Four in One" Innovative Talents Training Mode in Forensic MedicineJiang-Wei Yan, Jun-Hong Sun, Hong-Xing Wang, et al.
Frontiers in Cellular and Infection Microbiology|July 22, 2021
MicroRNA and circRNA Expression Analysis in a Zbtb1 Gene Knockout Monoclonal EL4 Cell LineJun-Hong Wang, Chun-Wei Shi, Yi-Yuan Lu, et al.
British Journal of Haematology|January 18, 2021
High infiltration of CD20<sup>+</sup> B lymphocytes in extranodal natural killer/T-cell lymphoma is associated with better prognosisMin-Min Chen, Guo-Peng Zeng, Jing Li, et al.
Scientific Reports|September 13, 2024
Differential genotoxicity of Polygoni Multiflori in rat and human: insights from Ames test and S9 metabolic activation systemSu-Min Bak, Seng-Min Back, Da Yeon Kim, et al.
JACC. Cardiovascular Interventions|April 24, 2025
Proportion and Clinical Impact of Stent Optimization During Imaging-Guided Percutaneous Coronary Intervention: The OCTIVUS TrialHoyun Kim, Do-Yoon Kang, Jung-Min Ahn, et al.
Journal of Clinical Neurology (Seoul, Korea)|January 17, 2020
Reliability and Validity of a Short Form of the Korean Dementia Screening Questionnaire-CognitionAhro Kim, SangYun Kim, Kyung Won Park, et al.
Molecules and Cells|March 28, 2015
Heme oxygenase-1 determines the differential response of breast cancer and normal cells to piperlongumineHa-Na Lee, Hyeon-Ok Jin, Jin-Ah Park, et al.
Drug Design, Development and Therapy|May 27, 2026
Efficacy and Safety of Telmisartan 20 mg/S-Amlodipine 2.5 mg versus Telmisartan 40 mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 TrialJong-Chan Youn, Eui-Soon Kim, Tae Ho Park, et al.
Signal Transduction and Targeted Therapy|June 18, 2023
Soluble CD4 effectively prevents excessive TLR activation of resident macrophages in the onset of sepsisSheng-Yuan Zhang, Qiu-Ping Xu, Li-Na Shi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2022
The FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC) trialTae-Hyun Yoo, Soon Jun Hong, Sunggyun Kim, et al.
Pageof 209